Evidence map›Paper›PMID 21177897›Full record

ArticleJournal of clinical microbiology2011

Development and evaluation of a real-time PCR assay for detection and quantification of blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies.

Philippe Poirier, Ivan Wawrzyniak, Aurélie Albert, Hicham El Alaoui, Frédéric Delbac, Valérie Livrelli

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. MappingOne health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
  6. Occurrence and subtyping of the intestinal protozoanFood and waterborne parasitology · 2026
    Article
  7. MultipleFood and waterborne parasitology · 2025
    Article
  8. Article
  9. Molecular Identification ofJournal of clinical medicine · 2025
    Article
  10. Article
  11. Article
  12. Targeted-Amplicon NGS forVeterinary sciences · 2025
    Article
  13. AnthropogenicMicroorganisms · 2025
    Article
  14. Investigation ofAfrican health sciences · 2025
    Article
  15. First Report on the Frequency and Subtype Distribution ofAnimals : an open access journal from MDPI · 2025
    Article
  16. Molecular detection of zoonoticalFrontiers in veterinary science · 2025
    Article
  17. Frontiers in microbiology · 2025
    Article
  18. ISME communications · 2025
    Article
  19. Article
  20. Blastocystis hominis; Friend or Foe.Integrative medicine (Encinitas, Calif.) · 2024
    Review

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philippe PoirierClermont Université, JE 2526, Evolution des bactéries pathogènes et susceptibilité de l'hôte, BP 10448, F-63000 Clermont-Ferrand, France.
Ivan Wawrzyniak
Aurélie Albert
Hicham El Alaoui
Frédéric Delbac
Valérie Livrelli

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blastocystis anaerobic parasites are widespread worldwide in the digestive tract of many animal species, including humans. Epidemiological Blastocystis studies are often limited by the poor sensitivity of standard parasitological assays for its detection. This report presents a highly sensitive real-time quantitative PCR (qPCR) assay developed to detect Blastocystis parasites in stool samples. The assay targets a partial sequence of the Blastocystis small ribosomal subunit (SSU) rRNA gene, allowing subtyping (ST) of Blastocystis isolates by direct sequencing of qPCR products. This qPCR method was assessed in a prospective study of 186 patients belonging to two cohorts--a group of 94 immunocompromised patients presenting hematological malignancies and a control group of 92 nonimmunocompromised patients. Direct-light microscopy and xenic in vitro stool culture analysis showed only 29% and 52% sensitivity, respectively, compared to our qPCR assay. Of the 27 (14.5%) Blastocystis-positive patients, 8 (4%) experienced digestive symptoms. No correlation was found between symptomatic patients and immune status, parasite load, or parasite subtypes, although subtyping of all isolates revealed a high (63.0%) prevalence of ST4. Two unexpected avian subtypes were found, i.e., ST6 and ST7, which are frequently isolated in Asia but rarely present in Western countries. In conclusion, this qPCR proved by far the most sensitive of the tested methods and allowed subtype determination by direct sequencing of qPCR products. New diagnostic tools such as the qPCR are essential for evaluating the clinical relevance of Blastocystis subtypes and their role in acute or chronic digestive disorders.

Indexed as

AdultAgedBlastocystisBlastocystis InfectionsDNA, ProtozoanDNA, RibosomalFecesFemaleHematologic NeoplasmsHumansMaleMiddle AgedMolecular TypingParasitologyPolymerase Chain ReactionProspective StudiesDNA, ProtozoanDNA, RibosomalRNA, Ribosomal

Identifiers

PMID21177897
PMCPMC3067686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.